Close Menu
Search
Reinventing Medicine
Redefining Treatment Paradigms
About Us
Our Company
Leadership
Kymera Cares
Science & Innovation
Our Approach
Pipeline
Resource Library
Careers & Culture
Working at Kymera
Open Positions
Patients
Media
Investors
Patients
Media
Investors
Reinventing Medicine
Redefining Treatment Paradigms
About Us
Our Company
Leadership
Kymera Cares
Science & Innovation
Our Approach
Pipeline
Resource Library
Careers & Culture
Working at Kymera
Open Positions
Search
Back to All Resources
Expression & Characterization of Novel Tissue Selective E3 Ligases
October 25, 2022
5th Annual Targeted Protein Degradation (TPD) Summit
View Presentation
Area of Focus
Platform
Targeted Protein Degradation
Programs
Other
Development Stage
Pre-clinical Data
Share
You may also be interested in these resources
August 15, 2022
MQAtlas Creates a Deep, Accurate and Global E3 Expression Atlas Enabling Targeted Protein Degradation Based Precision Medicine
The 14th International Symposium on Mass Spectrometry in the Health and Life Sciences
View Resource
June 6, 2022
Discovery and targeted mass spectrometry-based proteomics: Enabling technologies advancing IRAK4 protein degrader along the drug discovery pipeline into the clinic
The American Society for Mass Spectrometry (ASMS) Annual Conference
View Resource
December 7, 2022
Proteomics enabling TPD Drug Discovery
TPD Assay Development and Screening Summit
View Resource